Biotech companies by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 19 biotech companies ranked by P/S ratio, at 1777, ahead of CRISPR Therapeutics (1125) and Kymera Therapeutics (264). Figures as of 18 Nov 2026, 19:53 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
19
First
CG Oncology1777
Median
14.3
Combined market value
SAR 3.14T
Countries
5
Not ranked
5no P/S ratio on file

Market values as of .

All countries
All sectors
Biotech
SAR
Clear filters
Biotech companies by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1777SAR 26.9BSAR 301.47 1.81% up 85% up United States
2CRISPR TherapeuticsCRSP · Health Care1125SAR 14.8BSAR 152.76 1.43% up 21% down Switzerland
3Kymera TherapeuticsKYMR · Health Care264SAR 38.8BSAR 454.92 0.20% down 87% up United States
4ImmunityBioIBRX · Health Care63.1SAR 26.8BSAR 25.19 7.27% up 193% up United States
5ModernaMRNA · Health Care41.3SAR 301.1BSAR 744.27 4.05% down 755% up United States
6Krystal BiotechKRYS · Health Care23.9SAR 34.9BSAR 1,179.16 5.30% up 46% up United States
7Twist BioscienceTWST · Health Care21.1SAR 29.8BSAR 436.77 3.96% up 340% up United States
8Adaptive BiotechnologiesADPT · Health Care16.6SAR 17.2BSAR 106.55 0.30% down 88% up United States
9RepligenRGEN · Health Care14.8SAR 41.1BSAR 642.85 5.67% up 5% up United States
10argenxARGX · Health Care14.3SAR 222.7BSAR 3,540.72 0.38% down 4% up Belgium
11Bio-TechneTECH · Health Care9.4SAR 42.9BSAR 273.00 0.21% up 26% up United States
12Halozyme TherapeuticsHALO · Health Care7.9SAR 41.1BSAR 360.92 0.26% up 37% up United States
13ExelixisEXEL · Health Care7.2SAR 62.8BSAR 257.51 0.22% up 63% up United States
14Gilead SciencesGILD · Health Care7.1SAR 787.2BSAR 634.67 0.62% down 33% up United States
15AmgenAMGN · Health Care6.5SAR 899.8BSAR 1,663.44 3.16% down 34% up United States
16BioNTechBNTX · Health Care6.5SAR 77.7BSAR 313.23 1.60% down 16% down Germany
17Neurocrine BiosciencesNBIX · Health Care5.8SAR 62.1BSAR 613.94 1.35% down 20% up United States
18QiagenQGEN · Health Care4.9SAR 38.4BSAR 185.99 0.33% down 12% up Netherlands
19BiogenBIIB · Health Care3.7SAR 138.7BSAR 938.56 0.23% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies rank first by P/S ratio?

CG Oncology (1777), CRISPR Therapeutics (1125) and Kymera Therapeutics (264) are the top three of the 19 biotech companies ranked by P/S ratio as of 18 Nov 2026, 19:53 UTC.

How many biotech companies are in this ranking?

19 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 19 biotech companies ranked by P/S ratio have a combined market value of SAR 3.14T as of 18 Nov 2026, 19:53 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.